Revium Rx (RVRC) Assets (2024 - 2025)

Revium Rx recorded quarterly Assets of $8.3 million in Q4 2025, down 59.1% quarter-over-quarter from $20.3 million in Q4 2024, and down 59.1% year-over-year from $20.3 million in Q4 2024.

Revium Rx's Assets history runs 2 years deep, the most recent figure standing at $8.3 million for Q4 2025.

  • In Q4 2025, Assets fell 59.1% year-over-year to $8.3 million; the TTM figure through Dec 2025 stood at $8.3 million (down 59.1% YoY), while the FY2025 annual figure was $8.3 million, down 59.1% from the prior year.
  • Assets came in at $8.3 million for Q4 2025 at Revium Rx, down from $20.3 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $20.3 million in Q4 2024 to a low of $8.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 8.98 Bn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 6.21 Bn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 3.31 Bn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 728.77 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 1.12 Bn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 5.84 Bn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 1.02 Bn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 1.42 Bn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 2.00 Bn
10 Revium Rx - - - 8.30 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 8.30 Mn
Dec 31, 2024 20.28 Mn